Glypican 1 (GPC1) was used to isolate TEX from plasma of patients with pancreatic cancer [29], and prostate-specific membrane antigen (PSMA) was used to isolate TEX from plasma of prostate cancer patients [30]. This evidence concerns the gene GPC1 and familial pancreatic carcinoma.